HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1,3- dimethyl- 1,3- (4- fluorophenyl)- 1,3- (3- butyl- (1- piperazinyl)propyl)- 1,3- disiloxane

a multidrug-resistance reverting agent; structure in first source
Also Known As:
ALIS 421; ALIS-421; ALIS421
Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Molnar, Joseph: 2 articles (05/2013 - 03/2008)
2. Mucsi, Ilona: 1 article (05/2013)
3. Maoka, Takashi: 1 article (05/2013)
4. Olszewski, Ulrike: 1 article (05/2013)
5. Engi, Helga: 1 article (05/2013)
6. Vasas, Andrea: 1 article (05/2013)
7. Tokuda, Harukuni: 1 article (05/2013)
8. Amaral, Leonard: 1 article (05/2013)
9. Suzuiki, Nobutaka: 1 article (05/2013)
10. Hohmann, Judit: 1 article (05/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. 1,3- dimethyl- 1,3- p- fluorophenyl- 1,3- (3- morpholinopropyl)- 1,3- disiloxane
2. Antigens
3. Epstein-Barr virus early antigen
4. Carbon Monoxide
5. Silicon Compounds
6. Rhodamines